主页 > 生命科学 >

【medical-news】自身抗体水平升高与先兆子痫有关

Elevated Autoantibodies Linked to Preeclampsia

03/15/07 -- Women who develop preeclampsia during pregnancy are more likely to develop certain dangerous autoantibodies than women with normal pregnancies, and these autoantibodies are still present two years after childbirth in about 20 percent of women who had the disorder, scientists from the University of Pittsburgh report in the March issue of Hypertension, the journal of the American Heart Association.

Also known as toxemia, preeclampsia affects some 5 percent of pregnancies and is a leading cause of maternal and fetal illness and death, particularly in developing nations. Signs include high blood pressure, swelling of the ankles and the presence of protein in the urine. The condition typically appears after the mid-point of pregnancy. The only effective treatment is immediate delivery, which can be dangerous for the baby if it is too early. Untreated, the condition can lead to organ failure, coma and death. Preeclampsia also has been linked to an increased lifetime risk for heart disease.

"Further study is required to determine whether the presence of these autoantibodies could be an early marker for preeclampsia risk, but early data are promising," said Carl A. Hubel, Ph.D., the study抯 lead author and assistant professor of obstetrics, gynecology and reproductive sciences at the University of Pittsburgh School of Medicine. "Learning more about these autoantibodies also might enable us to identify a subset of women who are at greater risk for heart disease later in life, and give us a closer understanding of what causes preeclampsia."

For most women, the autoantibodies eventually go away after pregnancy. "But in some, they persist or reappear, consistent with other data showing that many of the risk factors for preeclampsia are the same as those for cardiovascular disease," added Dr. Hubel, who also is an associate investigator at the university-affiliated Magee-Womens Research Institute.

Autoantibodies are immune system proteins that attack the body抯 own cells instead of microorganisms that represent a real threat, such as viruses, bacteria or other toxins. Dr. Hubel and his colleagues studied the development of autoantibodies capable of activating the angiotensin II type 1 receptor (AT1-AA). The AT1 receptor is part of an amino acid group that works within cells to maintain healthy blood vessels and manage inflammation. Too much AT1 receptor activation, such as takes place when the autoantibodies are present, can lead to high blood pressure and inflammation.

"These antibodies are similar to antibodies in other conditions, such as those related to the autoimmune thyroid disorder Grave抯 disease," said Dr. Hubel. "These kinds of antibodies also are related to high blood pressure, which is one of the signs of preeclampsia. Women with a history of preeclampsia have a substantially higher cardiovascular risk later in life, compared to women who experienced normal pregnancies."

While the cause of preeclampsia remains unknown, evidence is mounting that the disorder relates to poor formation and placement of the placenta combined with underlying maternal factors including insulin resistance, obesity and inflammation that are magnified during the physiological stress of pregnancy.

Elevated levels of AT1-AA are evident in nearly all women with preeclampsia, the researchers report. Blood samples from 29 women with preeclampsia and 35 women who had normal pregnancies at Magee-Womens Hospital of UPMC in Pittsburgh and Massachusetts General Hospital in Boston were studied. The samples were collected between six months and two years postpartum to allow for stabilization of normal, pregnancy-induced cardiovascular changes.

"AT1-AA were detected in 17.2 percent of postpartum women who had developed preeclampsia, as opposed to 2.9 percent of postpartum women whose pregnancies were uncomplicated," said Dr. Hubel.

Source: University of Pittsburgh Schools of the Health Sciences

http://www.bio.com/newsfeatures/newsfeatures_research.jhtml?cid=27200007 本人已认领该文编译,48小时后若未提交译文,请其他战友自由认领。 Elevated Autoantibodies Linked to Preeclampsia
自身抗体水平升高与先兆子痫有关
03/15/07 -- Women who develop preeclampsia during pregnancy are more likely to develop certain dangerous autoantibodies than women with normal pregnancies, and these autoantibodies are still present two years after childbirth in about 20 percent of women who had the disorder, scientists from the University of Pittsburgh report in the March issue of Hypertension, the journal of the American Heart Association.
怀孕期间发生先兆子痫的妇女比那些正常妊娠的妇女更容易产生某种危险的自身抗体,而且20%的妇女在分娩后两年这些抗体仍然存在。匹兹堡大学的科学家在美国心脏病协会杂志《高血压》3月刊上报道说。

阅读本文的人还阅读:

【drug-news】小组:减肥药

硝酸甘油中间供体和血管

翻译的有关BMP的几篇摘要

【bio-news】自身免疫疾病

两个诺贝尔有关网站

作者:admin@医学,生命科学    2011-03-31 17:14
医学,生命科学网